¶ diabetes
¶ Definition
Diabetes mellitus is a chronic metabolic disorder characterized by sustained hyperglycemia (fasting glucose ≥126 mg/dL or HbA1c ≥6.5%) resulting from absolute insulin deficiency (Type 1 diabetes), progressive insulin resistance with eventual beta-cell failure (Type 2 Diabetes), or both. Type 2 diabetes represents a quintessential Evolutionary mismatch disease where metabolic adaptations evolved for surviving periodic famine—including thrifty genotype variants and insulin-mediated fat storage—become pathological under conditions of chronic caloric surplus, processed carbohydrate exposure, and physical inactivity. The condition drives systemic complications through multiple mechanisms: formation of advanced glycation end-products (AGEs), sustained Oxidative Stress, chronic low-grade inflammation (metaflammation), and microvascular/macrovascular damage affecting virtually every organ system.
¶ Picture It
Imagine your body as a city where glucose is the primary fuel delivery system. In Type 2 diabetes, it's like the fuel delivery trucks (Insulin) keep arriving at buildings (cells), but the loading dock doors (insulin receptors) are jammed with rust and debris (insulin resistance). At first, the city sends MORE trucks to compensate—this is hyperinsulinemia, the pancreas working overtime. But eventually, the truck factory (pancreatic beta cells) burns out from overproduction and can't keep up. Now fuel piles up in the streets (blood glucose stays elevated), where it starts caramelizing in the heat—this is glycation, where glucose literally sticks to proteins like burnt sugar coating street signs and pipes. This sticky caramel (AGEs) gums up the city's smallest capillaries (retina, kidneys, nerves), like molasses clogging drains. Meanwhile, the chronic fuel overflow triggers the city's alarm system (inflammation) into permanent overdrive, with inflammatory cytokines acting like sirens that never turn off. The Hunter-Gatherer Phenotype represents citizens whose loading docks were DESIGNED to be extra-efficient at capturing every fuel molecule during famines—brilliant for survival, disastrous when fuel deliveries never stop. The damage accumulates silently for years before the city infrastructure starts visibly failing: burst pipes (retinopathy), sewage backup (nephropathy), electrical shorts (neuropathy), and foundation cracks (cardiovascular disease).
¶ Mechanism
Type 1 Diabetes Pathway:
- Autoimmune T-cell attack on pancreatic beta cells via molecular mimicry (potentially triggered by viral antigens, cow milk proteins, or other environmental factors)
- CD4+ and CD8+ T-cells infiltrate islets → cytotoxic destruction
- Anti-GAD65, anti-IA-2, anti-insulin antibodies detectable
- Progressive loss of C-peptide production
- Absolute Insulin deficiency → unopposed glucagon → ketogenesis
- Risk: diabetic ketoacidosis (DKA) when ketones >3 mmol/L
Type 2 Diabetes Cascade:
-
Initiation (Insulin Resistance):
- Chronic excess caloric intake → adipocyte hypertrophy (especially visceral fat)
- Hypertrophied Adipocytes → hypoxia → HIF-1α activation
- Macrophage infiltration into adipose tissue → M1 polarization
- Pro-inflammatory cytokine release: TNF-α, IL-6, IL-1β, resistin
- TNF-α activates IKK-β → serine phosphorylation of IRS-1 at Ser307
- Serine-phosphorylated IRS-1 cannot transduce insulin receptor tyrosine kinase signals
- Result: impaired PI3K/Akt pathway → reduced GLUT4 translocation to cell membrane
- Muscle and fat cells fail to uptake glucose despite insulin presence
-
Compensation Phase:
- Pancreatic beta cells detect persistent hyperglycemia via GLUT1/GLUT2 glucose sensors
- Increased ATP/ADP ratio closes K-ATP channels → depolarization → Ca²⁺ influx
- Exocytosis of insulin granules increases 2-5 fold (hyperinsulinemia)
- Fasting insulin may reach 15-30 μU/mL (normal: 2-10 μU/mL)
- This maintains near-normal glucose for months to years
-
Beta-Cell Exhaustion:
- Chronic hyperglycemia → glucotoxicity → Oxidative Stress in beta cells
- Chronic hyperinsulinemia → lipotoxicity from free fatty acid oversupply
- Endoplasmic Reticulum Stress → CHOP activation → apoptosis
- Amylin co-secreted with insulin forms toxic amyloid deposits (islet amyloid polypeptide)
- Progressive beta-cell mass reduction (30-50% loss by diagnosis)
- Insulin secretion falls below demand → overt hyperglycemia
-
AGE Formation and Complications:
- Non-enzymatic glycation: glucose + protein amino groups → Schiff base → Amadori products (HbA1c) → irreversible AGEs
- AGEs cross-link collagen in blood vessel walls, basement membranes
- AGE-RAGE binding activates NF-kB → sustained inflammatory gene transcription
- RAGE expressed on endothelial cells, neurons, immune cells
- Microvascular damage: retinal capillaries (retinopathy), glomeruli (nephropathy), vasa nervorum (neuropathy)
- Macrovascular damage: accelerated atherosclerosis via endothelial dysfunction
-
Oxidative Stress Amplification:
- Hyperglycemia → mitochondrial electron transport chain overload
- Excess ROS production (superoxide O₂⁻)
- ROS damage mitochondrial DNA → impaired ATP synthesis
- Reduced Nitric Oxide bioavailability → vasoconstriction
- Polyol pathway activation: glucose → sorbitol via aldose reductase
- Sorbitol accumulation in nerves → osmotic stress → peripheral neuropathy
-
Hunter-Gatherer Phenotype Susceptibility:
- Polymorphisms in thrifty genotype genes (PPARG, TCF7L2, FTO)
- Enhanced insulin sensitivity during energy abundance → rapid fat storage
- Low HDL (<40 mg/dL men, <50 mg/dL women) due to altered lipoprotein metabolism
- High triglycerides (>150 mg/dL) from hepatic VLDL overproduction
- Fasting glucose 100-125 mg/dL despite "normal" weight sometimes
- HbA1c 5.7-6.4% indicating prediabetes stage
- These markers appear BEFORE clinical diabetes diagnosis
Neurological/Post-TBI Connection:
- traumatic brain injury → acute hypothalamic damage
- Disrupted insulin signaling in brain → central insulin resistance
- Rapid peripheral glucose dysregulation within 24-48 hours post-injury
- stroke → inflammatory cascade → systemic insulin resistance
- Myeloid cell infiltration independent of BBB breach
- Cytokine spillover affects peripheral glucose metabolism
¶ Clinical Significance
Diagnosis and Staging:
- Prediabetes: fasting glucose 100-125 mg/dL OR HbA1c 5.7-6.4% OR 2h-OGTT 140-199 mg/dL
- Diabetes: fasting glucose ≥126 mg/dL OR HbA1c ≥6.5% OR random glucose ≥200 mg/dL with symptoms
- HbA1c reflects 3-month average glucose (weighted toward recent 4-6 weeks)
- Every 1% increase in HbA1c above 6% = ~30 mg/dL average glucose increase
- Target HbA1c in most adults: <7% (stricter <6.5% if low hypoglycemia risk; relaxed <8% if elderly/comorbid)
Hunter vs Farmer Phenotype Metabolic Profiling:
The Hunter-Gatherer Phenotype shows metabolic markers indicating insulin resistance even before frank diabetes: inappropriately low HDL cholesterol (<40 mg/dL men, <50 mg/dL women), fasting glucose ≥100 mg/dL, triglycerides >150 mg/dL, HbA1c >5.7%. These individuals have genetic variants optimized for feast-famine cycles—enhanced insulin sensitivity during abundance rapidly stores energy as fat, but becomes pathological under continuous modern food availability. The Farmer phenotype (agricultural adaptations including AMY1 gene copy number variations) shows different metabolic risk patterns. This evolutionary lens explains why identical dietary patterns produce vastly different metabolic outcomes in different populations.
Evolutionary Mismatch Framework (Metamodel 0):
Type 2 diabetes exemplifies how Evolutionary mismatch drives modern disease. Our metabolism evolved for:
- Intermittent food availability (feast-famine cycles)
- High physical activity demands (10,000-20,000 steps/day)
- Nutrient-dense, low-glycemic whole foods
- Seasonal variation in food types
Modern mismatches include:
- Continuous food availability 24/7
- Processed carbohydrates causing rapid glucose spikes
- Sedentary behavior (
,000 steps/day common) - Year-round abundance of high-glycemic foods
70-90% of Type 2 diabetes cases are attributable to these lifestyle factors. This makes diabetes largely PREVENTABLE and often REVERSIBLE through addressing root causes rather than just managing symptoms.
Intervention Implications:
Lifestyle Interventions (Address Mismatch):
- Intermittent fasting: 16:8 time-restricted eating improves insulin sensitivity by 20-30%
- physical activity: Both aerobic and resistance training increase GLUT4 expression independent of insulin
- Muscle contraction activates AMPK → GLUT4 translocation bypassing insulin pathway
- Even single exercise session improves glucose uptake for 24-48 hours
- Dietary modification: reduce processed carbs, increase fiber (>30g/day), emphasize low-glycemic foods
- sleep optimization: <6 hours/night increases diabetes risk 28%
- stress management: chronic cortisol elevation antagonizes insulin signaling
When to Consider in cPNI Practice:
- Chronic fatigue with afternoon energy crashes (reactive hypoglycemia)
- Slow wound healing (AGE-related collagen dysfunction)
- Recurrent infections (impaired neutrophil function in hyperglycemia)
- chronic inflammation (diabetes perpetuates metaflammation)
- Cardiovascular disease risk stratification (diabetes = 2-4x CVD risk)
- Cognitive decline (brain insulin resistance overlaps with Alzheimer's pathology—"Type 3 diabetes")
- Depression resistant to treatment (inflammatory cytokines from metaflammation)
Pharmaceutical Context:
Medication (metformin, GLP-1 agonists, SGLT2 inhibitors) manages symptoms but does NOT reverse underlying insulin resistance or beta-cell dysfunction. Pharmaceutical-only approaches fail because they attempt to override fundamental metabolic mismatch rather than addressing root causes. However, medications can provide crucial glycemic control while lifestyle interventions take effect (typically 3-6 months for measurable HbA1c improvement).
Complications Timeline:
- Retinopathy: detectable in 20% at diagnosis, 60% by 15 years
- Nephropathy: microalbuminuria (30-300 mg/day) precedes overt kidney disease
- Neuropathy: affects ~50% of diabetics; starts distally (feet) due to longest axons
- neuropathic pain: burning, shooting pain from damaged vasa nervorum and direct glucose toxicity to nerves
- CVD: leading cause of death in diabetics (75% mortality from cardiovascular events)
Recovery Potential:
Studies show early Type 2 diabetes (duration <5 years) can achieve remission (HbA1c <6.5% without medication) in 40-60% of cases with intensive lifestyle intervention including:
- Weight loss 10-15% body weight
- Very-low-calorie diet (800 kcal/day) for 8-12 weeks followed by structured refeeding
- Daily physical activity 150+ minutes/week
- Sustained dietary changes emphasizing whole foods
¶ Key Facts
- Type 2 diabetes affects >537 million adults globally (2021), projected to reach 783 million by 2045
- HbA1c ≥6.5% diagnostic threshold; 5.7-6.4% indicates prediabetes with 5-10%/year progression to diabetes
- Fasting glucose ≥126 mg/dL diagnostic; 100-125 mg/dL indicates impaired fasting glucose (prediabetes)
- 2-hour post-OGTT glucose ≥200 mg/dL confirms diabetes; 140-199 mg/dL indicates impaired glucose tolerance
- Hunter-Gatherer Phenotype shows HDL <40 mg/dL (men)/<50 mg/dL (women), triglycerides >150 mg/dL, glucose ≥100 mg/dL, HbA1c >5.7% as early markers
- 70-90% of Type 2 diabetes cases attributable to modifiable lifestyle factors (diet, sedentary behavior, obesity)
- Every 1 kg/m² increase in BMI above 23 increases diabetes risk by 20%
- AGE accumulation from chronic hyperglycemia drives microvascular complications; detectable via skin autofluorescence
- Diabetic neuropathy affects ~50% of people with diabetes; small fiber neuropathy often first manifestation
- lifestyle interventions can reverse early Type 2 diabetes in 40-60% of cases within 6-12 months
- Each 1% reduction in HbA1c reduces microvascular complications by 25-30%
- Fasting insulin >15 μU/mL suggests hyperinsulinemia even if glucose normal (early insulin resistance)
- HOMA-IR (fasting insulin × fasting glucose ÷ 405) >2.5 indicates insulin resistance
- Diabetic ketoacidosis in Type 1: pH <7.3, ketones >3 mmol/L, glucose typically >250 mg/dL
- Metformin (first-line medication) works by inhibiting hepatic gluconeogenesis via AMPK activation
- Average time from prediabetes to overt diabetes: 5-10 years without intervention
- traumatic brain injury can trigger insulin resistance within 24-48 hours via hypothalamic inflammation
- Retinopathy screening should begin at diagnosis for Type 2, 5 years after diagnosis for Type 1
¶ Connections
- Type 2 Diabetes — the predominant form representing metabolic mismatch disease, accounting for 90-95% of diabetes cases
- insulin resistance — the core metabolic defect driving Type 2 pathogenesis through impaired IRS-1 signaling and reduced GLUT4 translocation
- Insulin — the pancreatic hormone whose deficiency (Type 1) or ineffectiveness (Type 2) defines all forms of diabetes
- hyperglycemia — chronic elevated blood glucose (≥126 mg/dL fasting) that defines diabetes and drives AGE formation
- HbA1c — glycated hemoglobin biomarker reflecting 3-month average glucose control; diagnostic threshold ≥6.5%
- metabolic syndrome — cluster of conditions (central obesity, hypertension, dyslipidemia, insulin resistance) that often precedes Type 2 diabetes
- obesity — major risk factor for Type 2 diabetes through adipocyte hypertrophy, chronic inflammation, and ectopic fat deposition
- Adipocytes — fat cells whose hypertrophy and inflammatory transformation drive insulin resistance via TNF-α and IL-6 secretion
- chronic low-grade inflammation — metaflammation mediating insulin resistance through IRS-1 serine phosphorylation and cytokine signaling
- AGEs — advanced glycation end-products formed from chronic hyperglycemia causing irreversible protein cross-linking and RAGE activation
- Oxidative Stress — excess ROS production from mitochondrial glucose overload damaging beta cells, endothelium, and nerves
- neuropathic pain — diabetic neuropathy causes painful peripheral nerve damage through vasa nervorum ischemia and glucose toxicity
- peripheral neuropathy — distal nerve damage from chronic hyperglycemia affecting sensory, motor, and autonomic fibers
- Cardiovascular disease — diabetes increases CVD risk 2-4 fold through accelerated atherosclerosis, endothelial dysfunction, and AGE accumulation
- Evolutionary mismatch — Type 2 diabetes exemplifies disease arising from mismatch between hunter-gatherer genetics and agricultural/industrial food environment
- Hunter-Gatherer Phenotype — metabolic phenotype with thrifty genotype showing early insulin resistance markers (low HDL, high triglycerides, elevated glucose)
- thrifty genotype — genetic variants conferring enhanced fat storage during abundance; adaptive for famine survival, pathological under continuous food availability
- Intermittent fasting — intervention improving insulin sensitivity 20-30% through AMPK activation, autophagy, and metabolic switching
- physical activity — increases insulin sensitivity and glucose uptake via AMPK-mediated GLUT4 translocation independent of insulin signaling
- traumatic brain injury — triggers rapid metabolic dysfunction including insulin resistance within 24-48 hours through hypothalamic damage and inflammatory cascade
- stroke — activates systemic inflammatory response causing insulin resistance and glucose dysregulation through cytokine-mediated IRS-1 serine phosphorylation
- inflammation — adipose tissue inflammation mediates transition from obesity to diabetes via M1 macrophage infiltration and pro-inflammatory cytokine release
- GLUT1 — constitutive glucose transporter in brain and red blood cells; insulin-independent, protecting cerebral glucose uptake during fasting
- GLUT4 — insulin-responsive glucose transporter in muscle and fat; translocation to membrane impaired in insulin resistance
- TNF-α — pro-inflammatory cytokine from hypertrophied adipocytes that directly impairs insulin signaling through IRS-1 serine phosphorylation
- IL-6 — pleiotropic cytokine elevated in diabetes; promotes hepatic glucose output and contributes to insulin resistance
- NF-kB — transcription factor activated by AGE-RAGE binding and inflammatory signals, perpetuating chronic inflammation
- adipose tissue — endocrine organ whose dysfunction in obesity drives systemic insulin resistance through inflammatory mediator release
- Endoplasmic Reticulum Stress — chronic protein misfolding stress in beta cells from glucotoxicity and lipotoxicity leading to apoptosis
- chronic inflammation — sustained low-grade systemic inflammation (metaflammation) linking obesity to insulin resistance and diabetes complications
- chronic stress — elevates cortisol which antagonizes insulin signaling and promotes hepatic gluconeogenesis, worsening glycemic control
- sleep — insufficient sleep (<6 hours) impairs glucose tolerance and insulin sensitivity; critical intervention target
- Mitochondrial dysfunction — impaired ATP production in muscle and beta cells from chronic hyperglycemia and oxidative damage
- gut microbiome — dysbiosis in diabetes shows reduced butyrate producers and increased LPS-producing bacteria driving endotoxemia
- butyrate — SCFA with insulin-sensitizing effects; reduced in diabetic dysbiosis
- Leptin — adipokine signaling satiety; leptin resistance parallels insulin resistance in obesity and diabetes
- cortisol — stress hormone promoting gluconeogenesis; chronic elevation contributes to insulin resistance
- BDNF — neurotrophic factor reduced in diabetes; exercise increases BDNF improving both metabolic and cognitive function
- lifestyle interventions — first-line treatment addressing root cause mismatch; can reverse early diabetes in 40-60% of cases
- Mismatch Disease — Type 2 diabetes as archetypal example of disease arising from gene-environment mismatch
¶ Module References
- Module 1 (Introduction - Evolutionary Medicine context, Hunter vs Farmer phenotypes, metabolic biomarkers)
- Module 1 (Neuroendocrinology - glucose transporters, insulin-independent brain glucose uptake, vasopressin-glucose interactions)